Cadila Healthcare Limited
•Download as PPTX, PDF•
4 likes•2,911 views
The document discusses the Indian pharmaceutical industry and Cadila Healthcare Limited. Some key points: 1. The Indian pharma industry is growing at 8-9% annually and meets 70% of India's drug demand. Cadila Healthcare is ranked 5th in the domestic market and manufactures drugs, vaccines, and consumer products. 2. Cadila spends over 12% of revenues on R&D and has a pipeline of biosimilars and vaccines. It focuses on new drug discovery and has over 950 researchers working across various therapeutic areas. 3. Financially, Cadila has grown its revenues and profits in recent years. Its domestic sales contribute 49% of total revenue. The company also pays
Report
Share
Report
Share
Recommended
Cadila healthcare
Cadila healthcare one of the prominent name in pharmaceuticals industry and growing product pipeline gives a long term growth vision to invest
Tanishq
Tanishq is India's largest jewellery brand, launched in 1995 by Titan. It initially struggled, making losses from 1995-1998. By introducing innovations like a karat meter to test purity and professional retail stores, Tanishq transformed the industry. It implemented strategies like standardized pricing, frequent design changes, and linking to gold price indexes. These changes helped Tanishq become the largest overseas jewellery chain in the US by 2001 and transform the Indian jewellery market. Going forward, Tanishq aims to focus on customers, ethics, IT investments, and global branding to further boost sales.
MARKET SHARE AND PRODUCT AVAILABILITY OF PARLE-G(Biscuits Division)
This is the presentation on the Market share and Product Availability of Parle-G(Biscuits Division) With Special Reference to Agra Region
Godrej company
This document provides an overview of the Godrej Group, an Indian conglomerate established in 1897. It discusses Godrej's founding by Ardeshir Godrej, the values of integrity, trust and respect that guide the company, and its growth into multiple business lines including locks, appliances, furniture, and personal care products. The document also outlines Godrej's vision, mission, history, products, subsidiaries, leadership, and the strengths and weaknesses of the overall business.
Company analysis of ambuja cement
It is a company analysis of Ambuja Cement. These type of ppts are many times required to be made for 1st year MBA students.
Emami Ltd. | Brand Analysis
This document includes various elements of Brand Analysis on India's leading FMCG (Ayurveda) firm- Emami Ltd. Makers of Navratna Oil, Fair & Handsome, Boroplus cream etc.
Corporate presentation on ONGC
This document is a report submitted by Sanket for their BBA degree at the Institute of Management Studies at Kurukshetra University. The report is on Oil & Natural Gas Corporation Limited and includes an acknowledgement, table of contents, and declarations. It discusses the energy sector in India, including its history and classification. It also covers the environmental impacts of the energy industry, such as pollution from fossil fuel combustion and potential benefits of renewable energy.
Patanjali ayurved
Patanjali Ayurved Ltd. is an Indian consumer goods company founded in 2006 that produces food, personal care, and Ayurvedic medicine products. Its vision is to become a top Ayurvedic company and introduce traditional Indian Ayurveda and yoga to the world. It chooses natural ingredients and aims to provide high quality, effective products at affordable prices. In 2016-17, Patanjali achieved a revenue of over 10,000 crore rupees and has become one of the largest fast-moving consumer goods companies in India in only 10 years.
Recommended
Cadila healthcare
Cadila healthcare one of the prominent name in pharmaceuticals industry and growing product pipeline gives a long term growth vision to invest
Tanishq
Tanishq is India's largest jewellery brand, launched in 1995 by Titan. It initially struggled, making losses from 1995-1998. By introducing innovations like a karat meter to test purity and professional retail stores, Tanishq transformed the industry. It implemented strategies like standardized pricing, frequent design changes, and linking to gold price indexes. These changes helped Tanishq become the largest overseas jewellery chain in the US by 2001 and transform the Indian jewellery market. Going forward, Tanishq aims to focus on customers, ethics, IT investments, and global branding to further boost sales.
MARKET SHARE AND PRODUCT AVAILABILITY OF PARLE-G(Biscuits Division)
This is the presentation on the Market share and Product Availability of Parle-G(Biscuits Division) With Special Reference to Agra Region
Godrej company
This document provides an overview of the Godrej Group, an Indian conglomerate established in 1897. It discusses Godrej's founding by Ardeshir Godrej, the values of integrity, trust and respect that guide the company, and its growth into multiple business lines including locks, appliances, furniture, and personal care products. The document also outlines Godrej's vision, mission, history, products, subsidiaries, leadership, and the strengths and weaknesses of the overall business.
Company analysis of ambuja cement
It is a company analysis of Ambuja Cement. These type of ppts are many times required to be made for 1st year MBA students.
Emami Ltd. | Brand Analysis
This document includes various elements of Brand Analysis on India's leading FMCG (Ayurveda) firm- Emami Ltd. Makers of Navratna Oil, Fair & Handsome, Boroplus cream etc.
Corporate presentation on ONGC
This document is a report submitted by Sanket for their BBA degree at the Institute of Management Studies at Kurukshetra University. The report is on Oil & Natural Gas Corporation Limited and includes an acknowledgement, table of contents, and declarations. It discusses the energy sector in India, including its history and classification. It also covers the environmental impacts of the energy industry, such as pollution from fossil fuel combustion and potential benefits of renewable energy.
Patanjali ayurved
Patanjali Ayurved Ltd. is an Indian consumer goods company founded in 2006 that produces food, personal care, and Ayurvedic medicine products. Its vision is to become a top Ayurvedic company and introduce traditional Indian Ayurveda and yoga to the world. It chooses natural ingredients and aims to provide high quality, effective products at affordable prices. In 2016-17, Patanjali achieved a revenue of over 10,000 crore rupees and has become one of the largest fast-moving consumer goods companies in India in only 10 years.
Financial Analysis Cadila Healthcare
Cadila Healthcare is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. It has 11 plants located across India and is the fourth largest pharmaceutical company in India. While Cadila's revenue grew to INR 54.7 billion in 2015, its profitability ratios have declined in recent years based on an analysis of its 2016-2017 financial statements. Most of Cadila's key ratios related to liquidity, leverage, profitability and returns have decreased, suggesting the company has not been performing efficiently. As a result, based on its current financial condition, Cadila cannot be recommended as a good investment opportunity.
Godrej
Godrej is an Indian conglomerate established in 1897 that operates in various industries including consumer goods, real estate, and industrial goods. Some key points from the document:
- Godrej started as a lock manufacturer and diversified into industries like home appliances, chemicals, and agri products. It has annual sales over $1 billion and a workforce of 18,000.
- Major associate companies include Godrej Properties, Godrej Consumer Products, Godrej Household Products, and Godrej Agrovet.
- Godrej has a presence across India with branch locations in major cities, and also operates internationally in countries like the UK, South Africa, and the UAE.
- The document provides
Gems and Jewellery Industry in India
The gems and jewellery industry in India is an important sector that is ranked among the fastest growing and is a leading foreign exchange earner. It has two major segments - gold, which comprises around 80% of the market, and diamonds, with India being the world's largest cutting and polishing center for diamonds. The industry has an annual growth rate of approximately 15% and exports over $15 billion worth of gems and jewellery annually. However, the industry faces threats from international competition and increasing gold and diamond prices.
Cipla final
Cipla is an India-based global pharmaceutical company whose goal is to ensure affordable medicine for all patients. It has a mission to be a leading healthcare provider using innovation and technology. Cipla has a competitive advantage of low-cost manufacturing through reverse engineering and a relative low-cost, high-skilled workforce in India. It is expanding globally through partnerships and acquisitions as patents expire on blockbuster drugs. Cipla is investing more in R&D and talent to develop new drugs and sustain its growth in international markets.
STP Analysis of Maggi
In this presentation, we have done a Segmentation, Targeting & Positioning (STP) Analysis of India's favourite instant noodle brand Maggi.
Britannia group- 11
This document provides an overview of Britannia Industries, a leading Indian FMCG company. It discusses Britannia's product portfolio including biscuits, bread and dairy products. The marketing mix of 4Ps - Product, Price, Place and Promotion strategies are described. Segmentation, targeting and positioning approaches are outlined focusing on demographic and behavioral segments. A BCG matrix shows the cash cow and star products. Finally, a SWOT analysis is presented and recommendations are made to focus on new product categories, pricing and international expansion.
Godrej Consumer Product lid(GCPL)
A presentation on Godrej Consumer Product ltd. (GCPL) which includes FMCG sector analysis, Marketing Analysis , HR duties in GCPL, Company Snapshot, Bloomberg Report for GCPL, financial Ratios, and a lot
Aashirvaad aata 4 p's
This document provides information about the Aashirvaad Atta brand owned by ITC Ltd. It discusses the company and brand background, product portfolio, marketing strategies used including segmentation, targeting, positioning, competition analysis, SWOT analysis, product management, pricing, promotion, and distribution channels. The key points are that Aashirvaad is India's number 1 atta brand with over 56% market share. It offers various atta variants at different price points and promotes the brand heavily through print, TV, and online advertisements emphasizing quality and health benefits.
Godrej
Godrej Consumer Products Limited (GCPL) is an Indian consumer goods company and subsidiary of the Godrej Group. It produces soap, hair colorants, household insecticides, and laundry detergents. GCPL segments its markets based on demographics, psychographics, behaviors, and geography. It targets both urban and rural Indian consumers through a large distribution network. GCPL positions its brands based on attributes, user benefits, competitors, quality, and price. Recent trends include focusing on research and development to create new products, standardize testing methods, and find alternative raw materials based on consumer feedback.
Glenmark
Glenmark has three API manufacturing facilities in India that produce over 100 APIs. It operates in India, Africa/Middle-East, Russia/CIS, Latin America, and Central and Eastern Europe. Glenmark has manufacturing sites in India, the Czech Republic, Brazil, Kenya, and Tanzania. It has a total of 300 products, including 22 patented products in India and 46 additional patented brands for international markets. Glenmark's supply chain strategy involves acquiring smaller companies that produce raw materials for its four global manufacturing locations.
HUL vs P&G
This document provides an overview of the Indian FMCG sector and Hindustan Unilever Limited (HUL). It discusses that the Indian FMCG sector is the 4th largest sector in India with an estimated size of Rs. 1,300 billion. It then lists the top 10 companies in the FMCG sector. The rest of the document focuses on providing details about HUL, including its mission, vision, portfolio of brands, strategies and financial performance.
indian business house godrej
This document provides information on Godrej Group, an Indian conglomerate founded in 1897. It discusses the origin and founder of Godrej, gives a brief history of the company's expansion over the decades into various sectors like FMCG, consumer electronics, engineering, IT, and more. The document also outlines Godrej's vision, management structure, strategies around being a first mover and pursuing globalization, and functional strategies focused on quality and efficiency. HR practices and CSR initiatives of the Godrej Group are also mentioned.
Balaji wafers ppt.pptx
Balaji Wafers was founded in 1974 in Rajkot, India by Chandubhai Virani and his brothers. It is a leading manufacturer of potato chips and namkeen, with over 5000 employees. Balaji Wafers aims to provide affordable snacks accessible across India through a large distribution network. Their vision is to grow into a global brand while maintaining traditions of trust and quality. Balaji Wafers dominates the Indian potato and vegetable chips market, increasing its share from 9.5% in 2008 to 13.7% in 2012.
Parle products ltd new fin. (1)
This document provides an overview of Parle Glucose biscuits (Parle G) produced by Parle Products in India. It discusses the history and evolution of Parle Products starting in 1929, their introduction of biscuits in 1939 including Parle G and Monaco, and how Parle fought to make biscuits affordable for all. It also summarizes Parle's market leadership in India with a 40% biscuit market share, their commitment to quality, extensive distribution network, and how Parle G became the world's largest selling brand of biscuits through its popularity across income levels and regions of India.
Haldirams Case Study
This document presents a marketing plan for Haldiram's namkeens (salty snacks) in Delhi, India. It includes an introduction to Haldiram's history and founders. It then discusses the company's mission, competitors, research methodology, growth plans, SWOT analysis, marketing mix, market segmentation, and conclusion. Key competitors identified are Frito-Lay, ITC, and Parle. The analysis finds that brand awareness and loyalty for Haldiram is very high among retailers and consumers in Delhi, though some younger consumers prefer competitors like Lehar and Bikano for certain products.
Parle G Report
This document provides information about Parle Products Pvt. Ltd., a leading Indian FMCG company. It discusses the company's history, founding in 1929 in Mumbai. It is currently split into three separate companies owned by different branches of the founding Chauhan family. The document provides details about Parle Products' leadership, factories, popular brands like Parle-G biscuits, financial information, and corporate social responsibility initiatives. It also gives an overview of the Indian biscuit industry.
Cadila Pharmaceuticals corporate presentation
Corporate presentation would provide users with basic information about our company, so you can know us better.
Colgate Company
In this assignment the objective of the assignment have mentioned. in which the introduction of the company is there, its mission statement, Achievements and past successes, customer awareness towards this company and many more.
Kalyan jewellers
Kalyan Jewellers is the largest jewellery chain in India, headquartered in Thrissur, Kerala. Founded in 1993, it targets the upper middle and high classes positioning itself as a royal brand. The company has shifted its advertising focus from full jewellery sets to just bangles, and spends heavily on advertising through hoardings, television, magazines and newspapers. The advertisement encourages customers to prioritize quality over price when purchasing gold jewellery.
Acc limited
ACC Limited is India's largest cement manufacturer with a network of 17 modern factories, 50+ ready-mix concrete plants, and over 10,000 dealers nationwide. It was formed in 1936 through the merger of 10 cement companies and is now owned by Holcim (LafargeHolcim). The document discusses ACC's organizational structure and key departments like customer service, finance, marketing, logistics, and sales. It also analyzes strengths like its large workforce and supply chain, as well as weaknesses like being a price follower. Opportunities in infrastructure and housing are noted, alongside threats from import duties, currency risks, and new coal cess taxes.
Working Capital Management
This document provides a history of the Indian pharmaceutical industry. It discusses how the industry grew after economic liberalization in the 1990s allowed Indian companies to enter generic drug manufacturing. It overtook the market share of multinational companies. The industry is now the 3rd largest producer globally by volume. It discusses the key players, regulations around patents, growth of exports, and challenges around research and development. It also provides an overview of the biotech sector in India and how it is growing but still smaller than the pharmaceutical industry.
Cadila Corporate
Cadila Pharmaceuticals is an Indian pharmaceutical company established in 1951. Their vision is to be a leading global pharmaceutical player by 2010. They have over 3,500 employees including 1,300 in marketing and 400 scientists. Cadila has manufacturing facilities in India and an overseas joint venture in Ethiopia. They focus on key therapeutic areas and have developed several novel products, including the world's first parenteral formulation of Rabeprazole. Cadila aims to provide integrated healthcare solutions and be a one-stop global outsourcing partner through contract manufacturing, research, licensing, and marketing services.
More Related Content
What's hot
Financial Analysis Cadila Healthcare
Cadila Healthcare is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. It has 11 plants located across India and is the fourth largest pharmaceutical company in India. While Cadila's revenue grew to INR 54.7 billion in 2015, its profitability ratios have declined in recent years based on an analysis of its 2016-2017 financial statements. Most of Cadila's key ratios related to liquidity, leverage, profitability and returns have decreased, suggesting the company has not been performing efficiently. As a result, based on its current financial condition, Cadila cannot be recommended as a good investment opportunity.
Godrej
Godrej is an Indian conglomerate established in 1897 that operates in various industries including consumer goods, real estate, and industrial goods. Some key points from the document:
- Godrej started as a lock manufacturer and diversified into industries like home appliances, chemicals, and agri products. It has annual sales over $1 billion and a workforce of 18,000.
- Major associate companies include Godrej Properties, Godrej Consumer Products, Godrej Household Products, and Godrej Agrovet.
- Godrej has a presence across India with branch locations in major cities, and also operates internationally in countries like the UK, South Africa, and the UAE.
- The document provides
Gems and Jewellery Industry in India
The gems and jewellery industry in India is an important sector that is ranked among the fastest growing and is a leading foreign exchange earner. It has two major segments - gold, which comprises around 80% of the market, and diamonds, with India being the world's largest cutting and polishing center for diamonds. The industry has an annual growth rate of approximately 15% and exports over $15 billion worth of gems and jewellery annually. However, the industry faces threats from international competition and increasing gold and diamond prices.
Cipla final
Cipla is an India-based global pharmaceutical company whose goal is to ensure affordable medicine for all patients. It has a mission to be a leading healthcare provider using innovation and technology. Cipla has a competitive advantage of low-cost manufacturing through reverse engineering and a relative low-cost, high-skilled workforce in India. It is expanding globally through partnerships and acquisitions as patents expire on blockbuster drugs. Cipla is investing more in R&D and talent to develop new drugs and sustain its growth in international markets.
STP Analysis of Maggi
In this presentation, we have done a Segmentation, Targeting & Positioning (STP) Analysis of India's favourite instant noodle brand Maggi.
Britannia group- 11
This document provides an overview of Britannia Industries, a leading Indian FMCG company. It discusses Britannia's product portfolio including biscuits, bread and dairy products. The marketing mix of 4Ps - Product, Price, Place and Promotion strategies are described. Segmentation, targeting and positioning approaches are outlined focusing on demographic and behavioral segments. A BCG matrix shows the cash cow and star products. Finally, a SWOT analysis is presented and recommendations are made to focus on new product categories, pricing and international expansion.
Godrej Consumer Product lid(GCPL)
A presentation on Godrej Consumer Product ltd. (GCPL) which includes FMCG sector analysis, Marketing Analysis , HR duties in GCPL, Company Snapshot, Bloomberg Report for GCPL, financial Ratios, and a lot
Aashirvaad aata 4 p's
This document provides information about the Aashirvaad Atta brand owned by ITC Ltd. It discusses the company and brand background, product portfolio, marketing strategies used including segmentation, targeting, positioning, competition analysis, SWOT analysis, product management, pricing, promotion, and distribution channels. The key points are that Aashirvaad is India's number 1 atta brand with over 56% market share. It offers various atta variants at different price points and promotes the brand heavily through print, TV, and online advertisements emphasizing quality and health benefits.
Godrej
Godrej Consumer Products Limited (GCPL) is an Indian consumer goods company and subsidiary of the Godrej Group. It produces soap, hair colorants, household insecticides, and laundry detergents. GCPL segments its markets based on demographics, psychographics, behaviors, and geography. It targets both urban and rural Indian consumers through a large distribution network. GCPL positions its brands based on attributes, user benefits, competitors, quality, and price. Recent trends include focusing on research and development to create new products, standardize testing methods, and find alternative raw materials based on consumer feedback.
Glenmark
Glenmark has three API manufacturing facilities in India that produce over 100 APIs. It operates in India, Africa/Middle-East, Russia/CIS, Latin America, and Central and Eastern Europe. Glenmark has manufacturing sites in India, the Czech Republic, Brazil, Kenya, and Tanzania. It has a total of 300 products, including 22 patented products in India and 46 additional patented brands for international markets. Glenmark's supply chain strategy involves acquiring smaller companies that produce raw materials for its four global manufacturing locations.
HUL vs P&G
This document provides an overview of the Indian FMCG sector and Hindustan Unilever Limited (HUL). It discusses that the Indian FMCG sector is the 4th largest sector in India with an estimated size of Rs. 1,300 billion. It then lists the top 10 companies in the FMCG sector. The rest of the document focuses on providing details about HUL, including its mission, vision, portfolio of brands, strategies and financial performance.
indian business house godrej
This document provides information on Godrej Group, an Indian conglomerate founded in 1897. It discusses the origin and founder of Godrej, gives a brief history of the company's expansion over the decades into various sectors like FMCG, consumer electronics, engineering, IT, and more. The document also outlines Godrej's vision, management structure, strategies around being a first mover and pursuing globalization, and functional strategies focused on quality and efficiency. HR practices and CSR initiatives of the Godrej Group are also mentioned.
Balaji wafers ppt.pptx
Balaji Wafers was founded in 1974 in Rajkot, India by Chandubhai Virani and his brothers. It is a leading manufacturer of potato chips and namkeen, with over 5000 employees. Balaji Wafers aims to provide affordable snacks accessible across India through a large distribution network. Their vision is to grow into a global brand while maintaining traditions of trust and quality. Balaji Wafers dominates the Indian potato and vegetable chips market, increasing its share from 9.5% in 2008 to 13.7% in 2012.
Parle products ltd new fin. (1)
This document provides an overview of Parle Glucose biscuits (Parle G) produced by Parle Products in India. It discusses the history and evolution of Parle Products starting in 1929, their introduction of biscuits in 1939 including Parle G and Monaco, and how Parle fought to make biscuits affordable for all. It also summarizes Parle's market leadership in India with a 40% biscuit market share, their commitment to quality, extensive distribution network, and how Parle G became the world's largest selling brand of biscuits through its popularity across income levels and regions of India.
Haldirams Case Study
This document presents a marketing plan for Haldiram's namkeens (salty snacks) in Delhi, India. It includes an introduction to Haldiram's history and founders. It then discusses the company's mission, competitors, research methodology, growth plans, SWOT analysis, marketing mix, market segmentation, and conclusion. Key competitors identified are Frito-Lay, ITC, and Parle. The analysis finds that brand awareness and loyalty for Haldiram is very high among retailers and consumers in Delhi, though some younger consumers prefer competitors like Lehar and Bikano for certain products.
Parle G Report
This document provides information about Parle Products Pvt. Ltd., a leading Indian FMCG company. It discusses the company's history, founding in 1929 in Mumbai. It is currently split into three separate companies owned by different branches of the founding Chauhan family. The document provides details about Parle Products' leadership, factories, popular brands like Parle-G biscuits, financial information, and corporate social responsibility initiatives. It also gives an overview of the Indian biscuit industry.
Cadila Pharmaceuticals corporate presentation
Corporate presentation would provide users with basic information about our company, so you can know us better.
Colgate Company
In this assignment the objective of the assignment have mentioned. in which the introduction of the company is there, its mission statement, Achievements and past successes, customer awareness towards this company and many more.
Kalyan jewellers
Kalyan Jewellers is the largest jewellery chain in India, headquartered in Thrissur, Kerala. Founded in 1993, it targets the upper middle and high classes positioning itself as a royal brand. The company has shifted its advertising focus from full jewellery sets to just bangles, and spends heavily on advertising through hoardings, television, magazines and newspapers. The advertisement encourages customers to prioritize quality over price when purchasing gold jewellery.
Acc limited
ACC Limited is India's largest cement manufacturer with a network of 17 modern factories, 50+ ready-mix concrete plants, and over 10,000 dealers nationwide. It was formed in 1936 through the merger of 10 cement companies and is now owned by Holcim (LafargeHolcim). The document discusses ACC's organizational structure and key departments like customer service, finance, marketing, logistics, and sales. It also analyzes strengths like its large workforce and supply chain, as well as weaknesses like being a price follower. Opportunities in infrastructure and housing are noted, alongside threats from import duties, currency risks, and new coal cess taxes.
What's hot (20)
Viewers also liked
Working Capital Management
This document provides a history of the Indian pharmaceutical industry. It discusses how the industry grew after economic liberalization in the 1990s allowed Indian companies to enter generic drug manufacturing. It overtook the market share of multinational companies. The industry is now the 3rd largest producer globally by volume. It discusses the key players, regulations around patents, growth of exports, and challenges around research and development. It also provides an overview of the biotech sector in India and how it is growing but still smaller than the pharmaceutical industry.
Cadila Corporate
Cadila Pharmaceuticals is an Indian pharmaceutical company established in 1951. Their vision is to be a leading global pharmaceutical player by 2010. They have over 3,500 employees including 1,300 in marketing and 400 scientists. Cadila has manufacturing facilities in India and an overseas joint venture in Ethiopia. They focus on key therapeutic areas and have developed several novel products, including the world's first parenteral formulation of Rabeprazole. Cadila aims to provide integrated healthcare solutions and be a one-stop global outsourcing partner through contract manufacturing, research, licensing, and marketing services.
Working Capital Management on Cadila Healthcare Limited.
This document provides background information on the history and development of the Indian pharmaceutical industry. It discusses how the industry grew after the 1970 Patent Act which removed composition patents from drugs and shortened process patents. This allowed Indian companies to enter the market and become a major global supplier of generic drugs. It also outlines key statistics on the current size and growth of the Indian pharmaceutical industry, which is now the 3rd largest producer globally and poised to become a $20 billion industry by 2015. The document notes that while many players are small-medium enterprises, foreign companies still control a large portion of the domestic market in India.
Cipla
The document discusses the financial accounting analysis of Cipla Ltd, an Indian pharmaceutical company. It includes an overview of Cipla, analysis of its balance sheet, cash flows, profitability ratios, share prices, earnings per share, price-earnings ratio and comparisons to competitors. The board of directors report highlights a 12% growth in domestic sales, 16% growth in exports, a 3% decline in operating margins, investments in new production facilities, a reduction in shareholder funds, 55% of revenues from international markets and contribution of $420 million in foreign exchange earnings.
Porter’S Five Force Model In Pharma Industries
This ppt describes well that how Porter's Five Force Model is used in Pharmaceutical Industris.......
Zydus
Group No. 4 set a vision in 2007 to achieve $1 billion in sales, dubbed the "Healthy Billion." In fiscal year 2010-2011, they crossed the $1 billion mark, achieving their goal. They now aspire to reach $3 billion in sales by 2015. The company maintained strong growth across its business segments including India formulations, international formulations, API and intermediates, animal health, and wellness. New product launches and geographic expansions contributed to the financial success.
Zydus cadila
To study the availability of new launched drugs of Zydus Cadila
Market Research was carried out in two cities of Gujarat- Ahmedabad and Rajkot- which gave an insight about the availability of newly launched products in medical stores. It also contains area wise availablity and leading brands.
Viewers also liked (7)
Working Capital Management on Cadila Healthcare Limited.
Working Capital Management on Cadila Healthcare Limited.
Similar to Cadila Healthcare Limited
Pharma Sector of INDIA
a brief about the pharma sector of India..which company are working in the Indian market and what is their respective positions...
4th annual pharmaceutical leadership summit
Pharmaleaders attempt is to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”
“Regarding the 2014, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014, we have been honoring outstanding scientific contributions for more than a decade and are privileged to recognize the work of accomplished leaders “As a true friend, philosopher & guide, we are deeply committed to creating a more sustainable future through scientific research and we will continue to support visionary pharma leaders as they strive to advance our understanding in all fields of the pharmaceutical & healthcare industry. “The Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards” was first bestowed in India in 19991 In order to reflect the increasingly global nature of the awards, it was then revaluated & reshaped in more credible formats in the year 2008 & since than these awards serve as a benchmark of innovation.
4th annual pharmaceutical leadership summit
l Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards
India’s only dedicated celebration of excellence in healthcare innovation, pharmaceutical & medical excellence and brand transformation.Pharmaleaders attempt is to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”
“Regarding the 2014, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014, we have been honoring outstanding scientific contributions for more than a decade and are privileged to recognize the work of accomplished leaders “As a true friend, philosopher & guide, we are deeply committed to creating a more sustainable future through scientific research and we will continue to support visionary pharma leaders as they strive to advance our understanding in all fields of the pharmaceutical & healthcare industry. “The Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards” was first bestowed in India in 19991 In order to reflect the increasingly global nature of the awards, it was then revaluated & reshaped in more credible formats in the year 2008 & since than these awards serve as a benchmark of innovation.
4th annual pharmaceutical leadership summit
Pharmaleaders attempt is to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”
“Regarding the 2014, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014, we have been honoring outstanding scientific contributions for more than a decade and are privileged to recognize the work of accomplished leaders “As a true friend, philosopher & guide, we are deeply committed to creating a more sustainable future through scientific research and we will continue to support visionary pharma leaders as they strive to advance our understanding in all fields of the pharmaceutical & healthcare industry. “The Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards” was first bestowed in India in 19991 In order to reflect the increasingly global nature of the awards, it was then revaluated & reshaped in more credible formats in the year 2008 & since than these awards serve as a benchmark of innovation.
ASSOCHAM_White_paper_091106
This document provides an overview of the Indian pharmaceutical industry and its quest for global leadership. It discusses the size and growth of the Indian pharmaceutical market, India's strategy to become a preferred global manufacturing base through low costs and regulatory approvals. It also outlines how Indian companies are establishing a global presence through acquisitions and partnerships. The document reviews India's policy and pricing framework, industry partnerships and deals, as well as contract research, manufacturing, clinical trials and drug development activities in India. It concludes with an outlook on future growth areas for the Indian pharmaceutical industry.
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docx
Running head: MARKET POSITION ANALYSIS 1
MARKET POSITION ANALYSIS 3
Market Position Analysis: Procter and Gamble in India
Market position analysis responds to the ‘how’ and the ‘what’ of the operations of a company in a target market. This analysis looks at the ‘what’ and ‘how’ of Procter and Gamble (P&G) in its operations in the India subcontinent. The purpose of the analysis is to consider how the company has succeeded in touching and improving the lives of its consumers amidst the growing competition in the emerging market. It is asserted that thegrowth of the company and sustainability of its operations is a function of superior brand propositioning and delivery of consumer goods in the Indian market.
Target Customer for the Product/Service
P&G is among the largest and fastest growing company dealing with consumer goods in the Indian market. This market in India offers P&G a huge potential of growth as a fast-growing consumer market. Among other factors the target market is comprised of three important characteristics of consumers that P&G targets among its consumers:
· The growing youth in its demographic profile
· The rising in the middle class
· Rising level ofincome among the middle class in India
It is projected that by 2020, India will offer one of the largest middle class population of the consumer market in the world. This is augmented by the projected total consumer expenditure of about $13 trillion by the year 2030.
Specific Wants and Needs of Customer Segment
The consumers in the market have three broad needs: personal hygiene and grooming, dental care, and home care. Among the youth, it is common for them to seek products for their personal care and hygiene (Sharma, 2014). These include such products that deal with theirhealthcare, feminine hygiene, and personal care. These are similar needs and wants of the growing middle-class segment. As such, the female youth go for Whisper for their feminine hygiene. However, it is common for them to also consume Halo Shampoo (hair care) and Palmolive Charmis Cream (for skin care) from Colgate Palmolive. The middle class seem keen on class products. For instance, theirrazors and other shaving products, dental products and other tertiary products like batteries reveal a tendency towards class. This is how Gillette India has been able to market such class products like Gillette razors, Oral-B, and Duracell batteries as shown in Fig 1. These are product classes that the main competitor, Colgate Palmolive does not offer in the market.
Fig 1: Product ranges moved by P&G by percentage (Majumdar, 2007)
How the Products Satisfy Customer Wants and Needs
In its oral care product segment, P&G offers customers with the Oral-B brand as an alternative to the Colgate’s oral care products. To meet the needs of the different consumers, they offer the product in toothbrush as well as toothpaste categories. This could be the motivation of the recent speculation of a possible launch of Crest (its .
Industry Monitor - Indian Healthcare Sector October 2014 (2)
This document provides an industry report on the Indian healthcare sector from October 2014. It includes sections on pharmaceuticals, industry statistics, product scans of x-ray machines and generic drugs, company and industry news, mergers and acquisitions, a company profile of Dr. Reddy's Laboratories, and upcoming events. Key highlights are the expected growth of the Indian pharmaceutical market to $55 billion by 2020, dominance of generic drugs, prevalence of counterfeit drugs, and focus on chronic disease segments and biologics.
An Exploratory Study on Customer Preferences towards Pathanjali Ayurvedic Pro...
FMCG market in India is facing tight competition from
the both domestic and international players. The awareness
towards the health related issues have given way for the
herbal and ayurvedic products in the same time. Ayurveda
is making way a big move into the air tight area of FMCG
and paving way towards success. A brand’s reputation is the
most valuable asset. In this digital era, and cluttered market
space where brands are jostling for visibility, their
reputation and credibility is what will set them apart.
Pathanjali the brand which is making big sales in the short
span with claiming the products are chemical free and herbal
and natural. Though Pathanjali, focis is on traditional food
products, soaps and toiletries it has diversified into the other
categories as well to grab the market. For example, Nestle’s
withdrawl of Maggie from the market when the instant
noodles had the harmful chemicals in the product, Pathanjali
used this opportunity to enter into the non- traditional
produce instatnt noodles though it mainly focus on the
traditional soaps and toiletries and FMCG products. The
FMCG market is so saturated and ruled by the gaints ,
Market entry of new brand is so difficult , pathanjali is
able to embrace the waves of swadeshi to sustain in the
market being the market challenger. This paper attempts to
explore how Pathanjali has been successful in this tight
competition and what made customers to accept Pathanjali.
The exploratory study is conducted to analyse the Customers
preferences towards ayurvedic and herbal products
especially the brand pathanjali.
DSP Healthcare Fund
The document discusses the DSP Healthcare Fund, an equity fund focused on investing in Indian and US healthcare companies. It highlights the large growth opportunity in the Indian healthcare industry given low penetration and spending levels currently. The fund aims to invest in companies across the healthcare ecosystem that benefit from rising healthcare expenditure, export opportunities, and the growing medical devices industry. Top holdings include Dr. Reddy's Laboratories, IPCA Laboratories and Divi's Laboratories based on their growth drivers and competitive advantages.
Summer Internship Report
Here are some key facts and figures about the global pharmaceutical industry:
- The global pharmaceutical market was estimated to be worth around $1.2 trillion in 2020. It is projected to reach $1.6 trillion by 2026.
- The top 10 global pharmaceutical companies by revenue in 2020 were Johnson & Johnson, Pfizer, Roche, Sanofi, Novartis, Merck & Co., AbbVie, GSK, Amgen, and Gilead Sciences.
- The top three pharmaceutical markets by sales in 2020 were the US at $360 billion, China at $145 billion, and Japan at $102 billion.
- The US accounted for around 40% of global pharmaceutical spending in 2020, despite
PPT of ziska pharma
Ziska pharma's strategic management development. Presented by a group IUBAT students. Prepared by Afsana Jaman.
Opportunities of BDS in Pharmaceutical Industries.pptx
India is the second-largest pharmaceutical market in Asia. ... A BDS graduate can have various job roles available in this sector: Principal Investigator, Co-investigator, Medical Advisor, Drug Developer, Regulatory Affairs Manager or even a Clinical Research Physician.
Career opportunities in the clinical research field are many and varied, with employment settings ranging from pharmaceutical and biotechnology, to medical device companies, contract research organizations, hospitals, educational institutions, independent contractors and more.
Many professionals with a strong science or healthcare related background — such as nurses, pharmacists, medical technologists, physicians and more — are well-positioned to join the clinical research field. Here are 10 career paths in the field.
Business to business project
JMI Syringe & Medical Device Company Ltd. manufactures and markets surgical devices in Bangladesh such as syringes, intravenous sets, and other medical supplies. It faces competition from other companies like Opso Saline but has established itself as the second largest provider. JMI aims to provide high quality, affordable products and expand its market both within Bangladesh and abroad. The report analyzes JMI's products, pricing strategies, target customers, and marketing challenges to understand how it can strengthen its position against competitors and become the market leader.
Business Plan
The document provides an overview of Synergies Care Limited (S.C.L), a proposed pharmaceutical manufacturing company in India. S.C.L will manufacture generic drugs at affordable prices on a 10-acre plot in Gurgaon, Haryana. It aims to attract over 1,000 weekday and 3,000 weekend customers in its first year, with sales forecasts of 18-30 crores. S.C.L will be privately owned and produce a wide range of medicines, with a focus on increasing its generics business through potential acquisitions in India and other markets.
HSN international Haridwar_project report
HR Project on Employee State Insurance at HSN International, Haridwar. HSN International is a pharmaceutical industry they are manufacturing the capsule and tablets.
31-8-2013
Z Score Model analysis on Pharma industry
This document provides an overview of the Indian pharmaceutical industry. It discusses the size and growth of the Indian economy and pharmaceutical industry. The pharmaceutical industry in India is the third largest by volume and is dominated by generic drugs, which account for 20% of global exports. The market size of the pharmaceutical industry in India is $20 billion and is expected to grow at a 20% CAGR over the next 5 years. The government has introduced several initiatives like allowing 100% FDI in pharmaceutical manufacturing and introduced new standards to enhance quality and help the industry's continued growth.
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
This document discusses the Indian pharmaceutical industry and its growth opportunities. It notes that India is a major global supplier of affordable, high-quality medicines and has significant manufacturing capabilities and regulatory approvals. The Indian drug market is large and growing, fueled by increasing access, acceptance, and affordability of medicines in India. Indian companies are also major exporters and are collaborating with international partners. R&D investment is growing to develop new products and capture patent expiration opportunities.
Api china-2013
The document discusses the Indian pharmaceutical industry and its advantages. It makes three key points:
1. The Indian pharmaceutical industry has grown significantly in recent decades and is now a major global supplier of generic drugs. It has over 700 member companies and exports over $12 billion worth of drugs annually.
2. India has many advantages that have fueled its pharmaceutical industry's growth, including a large skilled workforce, low production costs, and a large domestic market. It has received many regulatory approvals from agencies like the US FDA.
3. The growth of the Indian pharmaceutical industry has benefited global drug costs. As the largest producer and exporter of generic drugs, India has provided affordable treatment options and helped contain rising healthcare costs
Rbsa pharmaceutical industry analysis
The document provides an analysis of the Indian pharmaceutical sector, including background information, current trends, and performance of major players. It discusses key growth drivers for the industry like rising incomes and improved healthcare infrastructure. Major players are achieving steady profits, though pricing pressures have kept margins mostly flat recently. Companies with higher earnings efficiencies like Sun Pharma and Divis Lab command higher valuation multiples, while Elder Pharma has the lowest multiples due to lower profitability. The analysis also examines relationships between valuation metrics like EV/Sales and EBITDA margins for different firms.
WP-05.pdf
Cadila Healthcare Limited is an Indian pharmaceutical company that announced it was working on a COVID-19 vaccine called ZyCoV-D. The company saw significant growth in 2020 due to the pandemic. The document discusses Cadila's financial performance and history, provides an overview of the Indian pharmaceutical industry, and attempts an intrinsic and relative valuation of Cadila to estimate its five-year share price.
Similar to Cadila Healthcare Limited (20)
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docx
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docx
Industry Monitor - Indian Healthcare Sector October 2014 (2)
Industry Monitor - Indian Healthcare Sector October 2014 (2)
An Exploratory Study on Customer Preferences towards Pathanjali Ayurvedic Pro...
An Exploratory Study on Customer Preferences towards Pathanjali Ayurvedic Pro...
Opportunities of BDS in Pharmaceutical Industries.pptx
Opportunities of BDS in Pharmaceutical Industries.pptx
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
More from 92_neil
treasury management in corporates
The document discusses various aspects of treasury management in corporates. It covers topics like maintaining liquidity, managing financial risks, cash management, and tools to optimize cash flows. Cash management involves planning, forecasting, and controlling cash receipts and payments. It aims to determine the optimal level of cash balances through models like Baumol's model and Miller-Orr model. Tools like lockboxes, concentration banking, and netting can help speed up collections and reduce transaction costs.
STOCK EXCHANGE FUNCTIONING & BACK OFFICE MANAGEMENT
1. A stock exchange is an organized market where stocks and other securities are traded. It allows public trading of company shares and raises capital for businesses.
2. The first stock exchange was founded in Amsterdam in the 17th century. Major stock exchanges today include the New York Stock Exchange, NASDAQ, London Stock Exchange, and the two largest exchanges in India - Bombay Stock Exchange and National Stock Exchange.
3. A stock exchange facilitates trading through a network of brokers and trading systems. It allows for public listing and trading of company shares, mobilizes household savings for corporate investment, and provides price discovery and liquidity in financial markets.
buy back of shares
The document discusses buy-back of shares by a company. It introduces buy-back and outlines the key reasons for companies to buy-back shares such as signaling effect and increasing earnings per share. It also discusses the provisions governing buy-back under the Companies Act, 2013 including conditions, process, restrictions and tax treatment. Finally, it describes various methods of buy-back for both listed and unlisted companies.
substantial acquisition of shares and take overs (India)
The document provides an overview of substantial acquisitions of shares and takeovers in India, including definitions of key terms, the evolution and objectives of takeover regulations, types of takeovers and triggers for open offers. It discusses topics such as acquirers, target companies, control, promoters and promoter groups. The presentation also outlines the process, pricing and obligations in public announcements and open offers.
ADR and GDR : corporate financing
The document discusses various types of depository receipts (DRs) such as American Depository Receipts (ADRs) and Global Depository Receipts (GDRs). It explains that a DR allows investors to hold shares of foreign companies that trade on a local exchange. The document outlines the key parties involved in issuing DRs, including the issuer, depository, custodian bank and underwriters. It also describes the approval process for issuing DRs and the ongoing roles and responsibilities of each party.
hedge fund
This document provides an overview of hedge funds, including their history, structure, strategies, regulations and fees. It discusses how hedge funds were pioneered in 1949 and aim to generate absolute returns through a variety of investment techniques. The document outlines the key features of hedge fund regulations in India, including the different categories of funds, registration requirements, investment conditions and disclosure obligations. It also explains common hedge fund strategies like arbitrage, short selling, and event driven investments.
mutual fund
The document provides an overview of mutual funds in India, including their history, structure, guidelines, terms, types of funds, ratios, taxation, and future outlook. Some key points:
- A mutual fund pools money from investors and invests it in stocks, bonds, and other securities to generate returns. Returns and capital appreciation are shared proportionally by unit holders.
- SEBI regulates the mutual fund industry and has established a three-tier structure of sponsors, trustees, and asset management companies.
- There are various types of mutual funds that invest in different asset classes like equity, debt, hybrid, and money market instruments. Expense ratios, loads, and taxation vary across fund types.
IPO/FPO : Book building process
This document provides an overview of the IPO and FPO process in India. It defines IPO as the first sale of stock by a company to the public and FPO as when an already listed company makes a fresh issue of securities or an offer for sale. The key steps in the IPO process are Board approval, filing documents with SEBI and exchanges, IPO grading, setting the price band, book building, allotment and issuing the final prospectus. Intermediaries that help facilitate the process include merchant bankers, underwriters, syndicate members, registrars and bankers to the issue. The document also outlines SEBI regulations around eligibility criteria, minimum public shareholding and lock-in periods for IPOs and
Greening the supply chain
Business ethics and corporate governance concerning environment and the impact of greening the supply chain management
Fdi policy and its impact on India
This document discusses foreign direct investment (FDI) in India across several sectors. It defines FDI and compares it to foreign institutional investment. It outlines India's FDI policies for sectors like retail, telecom, pharmaceuticals, IT, automobiles and others. It discusses the types of FDI, top investing countries, trends over time, key players and investments, and impact of FDI policies on employment, technology, and economic growth in India. Charts and figures are provided on FDI flows and sector-wise cumulative inflows from 2000-2013.
Mrtp to competition when the world at large is a single platform for trade an...
The document discusses the progression from the MRTP Act to the Competition Act in India. Key points include:
- The MRTP Act focused on preventing concentration of economic power and controlling monopolies and restrictive/unfair trade practices.
- The Competition Act aims to promote competition and protect consumer interests. It prohibits anti-competitive agreements, abuse of dominant position, and regulates combinations.
- The Competition Commission of India was established to prevent practices having an appreciable adverse effect on competition in India. It has powers to conduct inquiries and impose penalties.
Polaroid
Polaroid introduced new consumer products like floppy disks and blank video tapes to expand into personal computer and video recorder markets. It developed new advertising with Ogilvy and Mather based on market research. It also changed dealer programs to improve relationships by giving dealers more flexibility. However, Polaroid had relied too long on instant film revenue and the perception that consumers always wanted hardcopy photos. It was slow to innovate and resisted electronics due to its film-focused culture. This "instant camera mentality" meant customers switched to options with more storage and editing, hurting Polaroid's demand over time. But Polaroid's new 1986 Spectra camera and marketing strategy showed annual revenues increasing 62% by 1992, making Polaroid
COMPARISON OF DTC WITH INCOME TAX ACT FOR BUSINESS INCOME
The document compares how business income is determined under the Direct Tax Code (DTC) and the Income Tax Act 1961.
Under both laws, income from any business carried out by the assessee during the year is taxable under the head "profits and gains from business". The DTC categorizes business expenses into operating expenses, finance charges, and capital allowances whereas the Income Tax Act covers these under multiple sections.
The DTC also provides separate schedules to compute income from specific businesses like insurance, shipping etc. and allows the government to notify if these schedules will not apply. The Income Tax Act contains similar but more detailed provisions to compute profits from different businesses under distinct heads.
the fashion channel
TFC faced increased competition that threatened its revenue and profits. To address this, it analyzed market research data to identify audience segments and evaluate targeting strategies. The document discusses 3 scenarios: 1) targeting all segments, 2) focusing only on "Fashionistas", and 3) targeting "Fashionistas and Planners". It recommends scenario 3 as it increases ratings and CPM the most while maintaining cable fees, generating the highest net income of $168M and profit margin of 39%.
Mindtree- financial/ratio analysis
Mindtree is an Indian global IT company headquartered in Bengaluru with over 13,000 employees. It has seen steady revenue growth over the past 5 years, with revenues increasing from $12.96 million in FY2010 to $30.31 million in FY2014. The majority of Mindtree's revenues come from clients in the US and Europe, with manufacturing, CPG and retail, and BFSI being the largest industries served. Mindtree has also improved its profitability over this period, with gross margins rising from 30% in FY2010 to 40% in FY2014.
Perception
This document discusses perception and related topics. It begins by defining perception as how individuals select, organize, and interpret stimuli to make sense of their environment. It then outlines several subprocesses of perception, including registration, interpretation, and feedback. The document discusses factors that influence perceptual selectivity, such as intensity, size, contrast, repetition, motion, novelty, and learning. It also examines social perception and impression management. Finally, the document notes the link between perception and individual decision-making, and provides a case study on how Skoda used public relations to change negative public perceptions of its brand.
Progression of MRTP Act to Competition Act in the era of globalization where ...
This document summarizes the progression from the MRTP Act of 1969 to the Competition Act of 2002 in India amid globalization. The MRTP Act aimed to control monopolies and restrictive trade practices. It was replaced by the Competition Act, which established the Competition Commission of India to prevent anti-competitive practices and protect consumer interests in a liberalized market. The key differences between the two acts are that the Competition Act is more proactive, defines competition offenses explicitly, and imposes penalties, seeking to foster fair competition amid India's economic reforms and openness to global trade.
More from 92_neil (17)
STOCK EXCHANGE FUNCTIONING & BACK OFFICE MANAGEMENT
STOCK EXCHANGE FUNCTIONING & BACK OFFICE MANAGEMENT
substantial acquisition of shares and take overs (India)
substantial acquisition of shares and take overs (India)
Mrtp to competition when the world at large is a single platform for trade an...
Mrtp to competition when the world at large is a single platform for trade an...
COMPARISON OF DTC WITH INCOME TAX ACT FOR BUSINESS INCOME
COMPARISON OF DTC WITH INCOME TAX ACT FOR BUSINESS INCOME
Progression of MRTP Act to Competition Act in the era of globalization where ...
Progression of MRTP Act to Competition Act in the era of globalization where ...
Recently uploaded
Industrial Tech SW: Category Renewal and Creation
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
Building Your Employer Brand with Social Media
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
The Evolution and Impact of OTT Platforms: A Deep Dive into the Future of Ent...
This presentation provides a thorough examination of Over-the-Top (OTT) platforms, focusing on their development and substantial influence on the entertainment industry, with a particular emphasis on the Indian market.We begin with an introduction to OTT platforms, defining them as streaming services that deliver content directly over the internet, bypassing traditional broadcast channels. These platforms offer a variety of content, including movies, TV shows, and original productions, allowing users to access content on-demand across multiple devices.The historical context covers the early days of streaming, starting with Netflix's inception in 1997 as a DVD rental service and its transition to streaming in 2007. The presentation also highlights India's television journey, from the launch of Doordarshan in 1959 to the introduction of Direct-to-Home (DTH) satellite television in 2000, which expanded viewing choices and set the stage for the rise of OTT platforms like Big Flix, Ditto TV, Sony LIV, Hotstar, and Netflix. The business models of OTT platforms are explored in detail. Subscription Video on Demand (SVOD) models, exemplified by Netflix and Amazon Prime Video, offer unlimited content access for a monthly fee. Transactional Video on Demand (TVOD) models, like iTunes and Sky Box Office, allow users to pay for individual pieces of content. Advertising-Based Video on Demand (AVOD) models, such as YouTube and Facebook Watch, provide free content supported by advertisements. Hybrid models combine elements of SVOD and AVOD, offering flexibility to cater to diverse audience preferences.
Content acquisition strategies are also discussed, highlighting the dual approach of purchasing broadcasting rights for existing films and TV shows and investing in original content production. This section underscores the importance of a robust content library in attracting and retaining subscribers.The presentation addresses the challenges faced by OTT platforms, including the unpredictability of content acquisition and audience preferences. It emphasizes the difficulty of balancing content investment with returns in a competitive market, the high costs associated with marketing, and the need for continuous innovation and adaptation to stay relevant.
The impact of OTT platforms on the Bollywood film industry is significant. The competition for viewers has led to a decrease in cinema ticket sales, affecting the revenue of Bollywood films that traditionally rely on theatrical releases. Additionally, OTT platforms now pay less for film rights due to the uncertain success of films in cinemas.
Looking ahead, the future of OTT in India appears promising. The market is expected to grow by 20% annually, reaching a value of ₹1200 billion by the end of the decade. The increasing availability of affordable smartphones and internet access will drive this growth, making OTT platforms a primary source of entertainment for many viewers.
Top mailing list providers in the USA.pptx
Discover the top mailing list providers in the USA, offering targeted lists, segmentation, and analytics to optimize your marketing campaigns and drive engagement.
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
In the recent edition, The 10 Most Influential Leaders Guiding Corporate Evolution, 2024, The Silicon Leaders magazine gladly features Dejan Štancer, President of the Global Chamber of Business Leaders (GCBL), along with other leaders.
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-inspired to the data-driven praxis (UA)
Kyiv PMDay 2024 Summer
Website – www.pmday.org
Youtube – https://www.youtube.com/startuplviv
FB – https://www.facebook.com/pmdayconference
Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership at Agile Tour Geneve 2024
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...
Dive into the steadfast world of the Taurus Zodiac Sign. Discover the grounded, stable, and logical nature of Taurus individuals, and explore their key personality traits, important dates, and horoscope insights. Learn how the determination and patience of the Taurus sign make them the rock-steady achievers and anchors of the zodiac.
Mastering B2B Payments Webinar from BlueSnap
B2B payments are rapidly changing. Find out the 5 key questions you need to be asking yourself to be sure you are mastering B2B payments today. Learn more at www.BlueSnap.com.
Business storytelling: key ingredients to a story
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
Authentically Social by Corey Perlman - EO Puerto Rico
Authentically Social by Corey Perlman - EO Puerto RicoCorey Perlman, Social Media Speaker and Consultant
Social media for business -- June 2024 is National Volunteer Month --
Check out our June display of books on voluntary organisations
Income Tax exemption for Start up : Section 80 IAC
A presentation on the concept of Exemption of Profits of Start ups from Income Tax
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Satta Matka
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Satta Matka➒➌➎➏➑➐➋➑➐➐Dpboss Matka Guessing Satta Matka Kalyan Chart Indian Matka
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Indian Matka Indian satta Matka Dpboss Matka Kalyan Chart Matka Boss otg matka Guessing Satta Creative Web Design Company in Singapore
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Recently uploaded (20)
The Evolution and Impact of OTT Platforms: A Deep Dive into the Future of Ent...
The Evolution and Impact of OTT Platforms: A Deep Dive into the Future of Ent...
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...
Authentically Social by Corey Perlman - EO Puerto Rico
Authentically Social by Corey Perlman - EO Puerto Rico
Income Tax exemption for Start up : Section 80 IAC
Income Tax exemption for Start up : Section 80 IAC
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
ModelingMarketingStrategiesMKS.CollumbiaUniversitypdf
The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
Training my puppy and implementation in this story
Training my puppy and implementation in this story
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Satta Matka
Dpboss Matka Guessing Satta Matta Matka Kalyan Chart Satta Matka
Cadila Healthcare Limited
- 1. Manshakaur Dhillon - 91 Darshit Ajmera - 92 Mayura Joshi - 93 Swati Agarwal - 94 Mohid Cutterwala - 95 Cadila Healthcare Limited
- 2. Indian Pharma Industry 4/9/2013MET’s ICS Economics Growing at about 8% to 9% annually. It meets around 70% of the country's demand. Reasons for rising demand for pharma products : 1. Low drug penetration 2. Rising middle-class & disposable income 3. Increased government & private spending 4. Increasing medical insurance penetration etc.
- 3. 4/9/2013MET’s ICS Economics Globally, India ranks 3rd in terms of manufacturing pharma products by volume. McKinsey & Company’s report, predicted that the Indian pharmaceuticals market will grow to US$55 billion in 2020 With aggressive growth strategies being implemented, it has further potential to reach US$70 billion by 2020
- 4. Cadila healthcare - Overview 4/9/2013MET’s ICS Economics Established in 1952 - Headquartered in Ahmedabad, Gujarat. Ranked 5th in the domestic market. Company evolved over the next four decades into one of India's renowned pharmaceutical companies. Cadila Healthcare became the Patel family's holding company in 1995 after the Modi families split
- 5. 4/9/2013MET’s ICS Economics IPO on Bombay Stock Exchange in 2000. Cadila manufactures a range of products:- 1. Formulations of active pharmaceutical ingredients (API) 2. Intermediates 3. Biologicals 4. Animal healthcare products 5. Consumer wellness products Cadila has a global presence.
- 6. 4/9/2013MET’s ICS Economics The group now has 81 patents and around 186 more pending. The product will have estimated sales of USD 3 billion in 2015. Cadila healthcare reported 1.33 % increase in net profit as on 7th August 2013 for the quarter ended June 30, 2013
- 7. 4/9/2013MET’s ICS Economics In 2012-13,Cadila’s R&D expenditure as a percentage of turnover was 12.67% It has a 950 member strong R&D team The company undertakes R&D activities in - Generics formulations New molecular entities Novel drug delivery systems Biologics Research & Development
- 8. 4/9/2013MET’s ICS Economics Cadila has a pipeline of 15 biosimilars(officially approved subsequent versions of innovative biopharmaceutical products) Cadila commissioned a manufacturing facility near Ahmedabad, which is catering to the global biosimilars business
- 9. R&D Expenditure break-up in 2012-13 (in crores) 4/9/2013MET’s ICS Economics API & Others, 26.8 NMEs & Drug Discovery, 59.8 Generics, 120.9
- 10. Break up of R&D team 4/9/2013MET’s ICS Economics 21% 37% 42% APIs & Others NMEs & Drug Discovery Generics
- 11. 4/9/2013MET’s ICS Economics Cadila is focusing on new drug discovery research in line with its long-term vision to become a global research- driven company by 2020. It has built the state-of-the-art Zydus Research Center (ZRC) with a dedicated research team of over 950 research professionals.
- 12. 4/9/2013MET’s ICS Economics Biologics - a key long-term opportunity given the intense competition in the global developed generics markets and the high entry barriers in the ‘Biologics’ field leading to lesser competition. Vaccines – another niche opportunity. The first achievement - the DCGI nod to start clinical trials of the vaccine for H1N1 Flu. It is the first Indian company to get such approval.
- 13. Major collaborations in past few years. 4/9/2013MET’s ICS Economics Zydus - Hospira JV in yr 2009 Zydus - Abbott Laboratories alliance in yr 2010 Bayer Zydus Pharma in yr 2011 Zydus - IDRI in yr 2013
- 14. CSR Initiatives 4/9/2013MET’s ICS Economics Ramanbhai Foundation: The Zydus School for Excellence Outreach programmes Theme - Colours of Life (to spread joy and happiness to the community) Tree plantation drive - ‘Each one, plant one’ It extends support during times of natural calamities. Social and Corporate Governance Award
- 15. 4/9/2013MET’s ICS Economics 74.79% 5.42% 9.92% 9.87% Promote r FII DII Others Shareholding pattern
- 16. 4/9/2013MET’s ICS Economics Break-up of revenue 49% 43% 8% Domestic Business Export Business JV
- 17. 4/9/2013MET’s ICS Economics 10 110 210 310 410 510 610 581.8 103.3 49.5 10.8 625.2 115 49.4 20 Jun- 12 Revenue from domestic business Revenue from export business 0 100 200 300 400 500 600 700 595.2 65 11.6 626.9 65.8 13 Jun-12 Jun-13
- 18. 4/9/2013MET’s ICS Economics 0 20 40 60 80 100 120 140 160 2009 2010 2011 2012 2013 90 100 125 150 150 Equity Dividend%
- 19. 4/9/2013MET’s ICS Economics 23.09% 23.09% 20.30% 20.96% 23.36% DIVIDEND PAYOUT RATIO 2009 2010 2011 2012 2013
- 20. 4/9/2013MET’s ICS Economics 0 0.2 0.4 0.6 0.8 1 1.2 2009 2010 2011 2012 2013 1.08 0.91 0.88 0.89 1 Asset Turnover Ratio 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 2009 2010 2011 2012 2013 0.7 0.67 0.37 0.27 0.43 Debt Equity Ratio
- 21. 4/9/2013MET’s ICS Economics 0 5 10 15 20 25 30 35 40 2009 2010 2011 2012 2013 18.8 19.48 36.87 29.81 32.11 Earnings Per Share 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2009 2010 2011 2012 2013 1 0.93 1.4 1.63 1.22 Current Ratio
- 22. 4/9/2013MET’s ICS Economics 0 100 200 300 400 500 600 700 2009 2010 2011 2012 2013 236.2 265.9 503.3 610.4 657.5 Profit After Tax
- 23. Future Prospects 4/9/2013MET’s ICS Economics Beyond the Billion VICA PRISM 15 markets India`s first Chemical Novel